Publicaciones científicas
Use of recombinant human granulocyte-macrophage colony stimulating factor in an infant with reticular dysgenesis
01-mar-1994
| Revista: European Journal of Pediatrics
Azcona C, Alzina V, Barona P, Sierrasesúmaga L, Villa-Elízaga I.
Resumen
We present the case of a 2-month-old infant with reticular dysgenesis who was treated with recombinant granulocyte-macrophage colony stimulating factor with the aim of stimulating granulopoiesis while awaiting bone marrow transplant.
CITA DEL ARTÍCULO Eur J Pediatr. 1994 Mar;153(3):164-6. doi: 10.1007/BF01958976.